Attovia Therapeutics, Inc. Common Stock (ATTO) Stock Price, Quote & AI Analysis

Live ATTO stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Attovia Therapeutics, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Attovia Therapeutics, Inc. Common Stock (ATTO), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.

A
ATTO
Attovia Therapeutics, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
24.440000
High
27.660000
Low
24.440000
Volume
311,049
VWAP
-
Market Cap
$1,166,389,744.10
52W Range
$16.15 - $27.66
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Attovia Therapeutics, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Attovia Therapeutics, Inc. Common Stock Overview

Company information

Company Overview

Attovia Therapeutics, Inc. is a biopharmaceutical company developing precision multispecific biologics to address immune-mediated and inflammatory diseases, including dermatology conditions such as atopic dermatitis and chronic pruritus, and gastroenterology disorders like inflammatory bowel disease. The company is based in San Carlos, CA. The company utilizes its proprietary Attobody™ platform to design novel multispecific molecules that inhibit multiple disease-driving pathways. Key pipeline candidates include ATTO-1310 (anti-IL31) and ATTO-3712 (anti-IL31 x IL13), both in phase 1 clinical trials for chronic pruritus and inflammatory skin disease, and ATTO-1091, a trispecific molecule in IND-enabling stages for inflammatory bowel disease. The company was founded in 2022 by Petter Veiby, Tao Fu, Zaneta Odrowaz. Tao Fu has been the CEO of the company since 2022.

Company Details
Market Cap
$1.16B
Shares Outstanding
45,651,262
Weighted Shares Outstanding
45,651,262
CEO
Tao Fu
Address
1091 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and indicators

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Attovia Therapeutics, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...